Newsummitbio

company

About

Shanghai Newsummit Biopharma is a Chinese provider of pharmaceuticals industrialization, modularization, and large-scale R&D services.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Industries
Biotechnology
Founded date
Jan 1, 2001
Number Of Employee
11 - 50
Operating Status
Active

Shanghai Newsummit Biopharma is a Chinese provider of comprehensive pharmaceuticals industrialization, modularization, standardization, and large-scale R&D services.

Newsummit is focused on the optimization and integration of industrial resources through the alliance of governance, production, education, research and capital, to serve scientists, entrepreneurs, investors, and the government. These services include assisting the scientists to facilitate the achievements of new medicine and realize the industrialization; providing entrepreneurs with achievements with industrial value and industry incubation; helping investors to shorten investment cycle and reduce investment risk; serving the government by integrating resources from China's New Medicines Public Service Platform; and strengthening the international competitiveness of China's New Medicines' self-research and development.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Newsummitbio has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 1, 2011 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2011 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Newsummitbio is funded by 1 investors. Sequoia Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Sequoia Capital Series Unknown